Oasys vs. Extreme H20 Xtra 59

Innovative Medical

Status and phase: Completed; Phase 4

Conditions: Dry Eye

Treatments: Drug: Restasis, Refresh Endura

Study type: Interventional

Funder types: Industry

Identifiers

NCT00477763

5300

Details and patient eligibility

About

To compare the performance of Oasys to Extreme H20 xtra 59 in dry eye contact lens pts who receive Restasis in 1 eye and vehicle (Endura) in the other eye.

Enrollment: 52 patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or Female at least 19 years of age
• Contact Lens Wearers
• Patients with mild to moderate symptoms of dry eye

Exclusion criteria

• male or female younger than 19 years of age

Trial design

52 participants in 2 patient groups, including a placebo group

1

Active Comparator group

Treatment:

Drug: Restasis, Refresh Endura

2

Placebo Comparator group

Treatment:

Drug: Restasis, Refresh Endura